Accéder au contenu
Merck

Tachykinin upregulation in atopic dermatitis.

Immunopharmacology and immunotoxicology (2019-02-19)
Louise Lönndahl, Aram Rasul, Sol-Britt Lonne-Rahm, Mikael Holst, Björn Johansson, Husameldin El-Nour, Diana Radu Djurfeldt, Klas Nordlind
RÉSUMÉ

Context: Atopic dermatitis (AD) is a chronic, inflammatory, itching skin disorder, which may worsen due to stress, depression and anxiety. Tachykinins may be involved in inflammation signaling as well as they may have a role in stress, depression and anxiety. Objective: This study aimed to measure the expression of tachykinin markers, in the skin of patients with AD, and the correlation of these tachykinins with clinical and psychodemographic parameters. Materials and methods: Twenty-eight adult patients with AD were investigated regarding tachykinin expression in skin biopsies, using an immunohistochemical technique. The patients were characterized with clinical and psychodemographic parameters. Results: The number of substance P and neurokinin (NK)A positive nerve fibers, as well as NKA positive mononuclear dermal cells, was increased in lesional compared to non-lesional skin. Interestingly, the depression score and the number of dermal NK-1 receptor (R) positive cells in lesional as well as in non-lesional skin showed a correlation. Conclusion: These findings indicate an upregulation of the tachykinergic system in the inflamed skin of AD.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anticorps anti-tryptase, mastocyte, clone G3, clone G3, Chemicon®, from mouse
Référence
Conditionnement
Disponibilité
Prix
Quantité